Robert G. Finizio, CEO, 10% Owner at TherapeuticsMD, Inc. (TXMD), sold 50,000 shares at $6.17 ($309K) on 2014-02-19, disclosed to the SEC on 2014-02-21.
Scheduled sale ($309k) by CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.17 | 16,700 | $103K | 33.4% |
| 2 | $6.17 | 16,700 | $103K | 33.4% |
| 3 | $6.18 | 16,600 | $103K | 33.2% |
| Total | $6.17 avg | 50,000 | $309K | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |